Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPain Managementmhn lysis of epidural lesions Coverage Update | Op…
    Ask Trek AI about this page
    CurrentmhnPolicy CP.MP.116

    Lysis of Epidural Lesions

    Customize your policy alerts

    Sign up for mhn Policy CP.MP.116 alerts

    Get alerted when Policy CP.MP.116 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines the payer's coverage stance and supporting background for percutaneous and endoscopic lysis of epidural adhesions for chronic low back and lower extremity pain; applies to providers and members of health plans affiliated with Centene Corporation.

    Policy Summary
    Payermhn
    PolicyLysis of Epidural Lesions
    Policy CodePolicy CP.MP.116
    Change TypeNo material change
    Effective Date
    Next Review Date
    Key ActionReference current professional coding guidance and verify CPT codes 62263 and 62264 prior to claim submission.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    1policy statement (efficacy not supported)
    2CPT codes listed

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    6RCTs referenced
    2021ASIPP guideline year
    2010NICE statement year
    3document chunks

    Coverage Criteria

    General coverage stance

    Policy: It is the policy of health plans affiliated with Centene Corporation that current medical literature does not support the efficacy of lysis of epidural lesions, including percutaneous epidural adhesiolysis and endoscopic epidural adhesiolysis, with or without use of an indwelling epidural Racz catheter.

    Direct coverage stance from policy.

    The policy states that current medical literature does not support the efficacy of lysis of epidural lesions. This includes both percutaneous epidural adhesiolysis and endoscopic epidural adhesiolysis, with or without use of an indwelling epidural Racz catheter. As a result, these procedures are not considered supported for efficacy under the health plans affiliated with Centene Corporation.

    Per the policy statement, lysis of epidural lesions is not supported by current medical literature for efficacy and therefore is not favorably covered under this clinical policy. This statement applies to both percutaneous and endoscopic approaches, regardless of use of an indwelling Racz catheter.

    For members enrolled in Medicaid, state Medicaid coverage provisions take precedence where they conflict with the coverage provisions in this clinical policy. Providers should consult the applicable state Medicaid manual for any differing coverage rules.

    Coding

    CPT CodesCPT
    62263Percutaneous lysis of epidural adhesions using solution injection (eg, hypertonic saline, enzyme) or mechanical means (eg, catheter) including radiologic localization (includes contrast when administered), multiple adhesiolysis sessions; 2 or more days.
    62264Percutaneous lysis of epidural adhesions using solution injection (eg, hypertonic saline, enzyme) or mechanical means (eg, catheter) including radiologic localization (includes contrast when administered), multiple adhesiolysis sessions; 1 day.

    Provider Actions & Operational Notes

    Prior Authorization

    Prior Authorization & Effective Date

    Prior authorization requirements and the effective date for this clinical policy are determined by the Health Plan. The date this policy is posted may not reflect the effective date that applies to a given member; providers should verify prior authorization requirements and the policy effective date with the member's specific Health Plan before submitting requests for services.

    • Verify prior authorization requirements and effective date with the member's Health Plan prior to scheduling or performing services.
    • Posting date may differ from the Health Plan-determined effective date; follow the Health Plan's operative effective date for coverage decisions.
    Documentation Required

    Coverage Decisions & Administration of Benefits

    Coverage decisions and administration of benefits are subject to the terms, conditions, exclusions and limitations of the member's coverage documents and applicable law and Health Plan administrative policies. This clinical policy is a guide to medical necessity and is not a guarantee of payment. Providers should confirm benefit coverage, applicable exclusions, and member-specific requirements (including prior authorization, network status, and benefit limits) before rendering services.

    Conservative Treatment Requirements

    Conservative treatment requirements

    Policy and cited literature discuss use after failure of conservative therapies; however, the policy does not find the evidence sufficient to support efficacy.

    Context: Evidence and guideline statements address percutaneous adhesiolysis for patients who have failed conservative therapy, but limitations in the evidence base are noted (small number of low-quality RCTs and lack of recent trials).

    Summarizes Hayes review and guideline context.

    Hayes review findings: A Hayes review of six randomized controlled trials (search through Sept 7, 2018) found a small body of low-quality evidence suggesting potential short- and intermediate-term benefit of percutaneous adhesiolysis in chronic low back pain unresponsive to other treatments, but long-term outcomes are undetermined and recent RCTs are lacking.

    Supports statement that evidence is limited.

    ASIPP guideline update: The 2021 ASIPP update rates the quality of evidence for percutaneous adhesiolysis as moderate to strong for certain indications after failure of conservative treatment (including disc herniation, spinal stenosis, and post-surgery syndrome), but notes a paucity of high-quality RCTs and does not address endoscopic adhesiolysis.

    Imaging Requirements

    Documentation Required

    Percutaneous/endoscopic adhesiolysis — include fluoroscopic localization

    Perform percutaneous or endoscopic adhesiolysis with radiologic (fluoroscopic) localization as described in the CPT code definitions; ensure fluoroscopic imaging is documented in the medical record.

    • CPT descriptions for 62263 and 62264 include radiologic localization (fluoroscopy) as part of the procedure.
    • Policy background notes adhesions may be identified as non-filling lesions on fluoroscopy and endoscopy provides direct visualization.

    Not Covered

    NOT COVERED: The policy explicitly states that lysis of epidural lesions (percutaneous epidural adhesiolysis and endoscopic epidural adhesiolysis), with or without an indwelling epidural Racz catheter, is not supported by current medical literature for efficacy and therefore is not favorably covered by health plans affiliated with Centene Corporation. Providers should also note that Medicaid-specific provisions may override this policy where applicable.

    Definitions

    Epidural adhesiolysis / lysis of epidural lesions — definition
    TermEpidural adhesiolysis (lysis of epidural lesions)
    DescriptionMinimally invasive procedure (percutaneous or endoscopic) for chronic back pain associated with epidural fibrosis/adhesions; may follow prior spinal surgery or degenerative spine disease.
    Techniques / agentsPercutaneous: epidural injections (e.g., hypertonic saline) often with steroids, analgesics, and/or hyaluronidase; mechanical catheter manipulation may be used.
    Endoscopic approachSpinal endoscopy permits direct visualization and targeted lysis via a flexible fiberoptic catheter inserted through the sacral hiatus for 3‑D guidance.
    MechanismHypertonic saline may mechanically disrupt adhesions and reduce edema; catheter manipulation can physically disrupt scar tissue; hyaluronidase may enhance drug penetration into scar.

    Background

    Background: Epidural adhesiolysis (percutaneous or endoscopic) is an interventional technique intended to treat chronic back and lower extremity pain attributed to epidural fibrosis or adhesions. Techniques described in the literature include injection of solutions (for example, hypertonic saline, enzymes, or steroids) and mechanical catheter disruption; endoscopic approaches permit direct visualization and targeted lysis. Despite these described techniques, the policy determination is that available evidence does not support efficacy for lysis of epidural lesions.

    Policy Summary
    Payermhn
    PolicyLysis of Epidural Lesions
    Policy CodePolicy CP.MP.116
    Change TypeNo material change
    Effective Date
    Next Review Date
    Key ActionReference current professional coding guidance and verify CPT codes 62263 and 62264 prior to claim submission.
    SourceLink
    On This Page
    Coverage CriteriaCodingProvider Actions & Operational NotesConservative Treatment RequirementsImaging RequirementsNot CoveredDefinitionsBackground
    • Coverage is subject to the member's evidence of coverage, certificate of coverage, policy, or contract of insurance and to state and federal requirements.
    • State Medicaid provisions supersede this clinical policy where conflicts exist; consult the state Medicaid manual for specific Medicaid coverage rules.
    • For Medicare members, review applicable NCDs, LCDs, and Medicare Coverage Articles at http://www.cms.gov prior to applying this policy's criteria.
    Billing Rule

    Coding, Documentation & Billing Notes

    Providers must reference current coding guidance prior to claim submission and ensure required documentation supports medical necessity per the Health Plan. Inclusion of CPT codes in this policy does not guarantee coverage.

    • Reference up-to-date professional coding guidance before submitting claims.
    • CPT codes referenced in this policy (for informational purposes) include 62263 and 62264; inclusion does not assure payment.
    • Ensure clinical documentation supports the medical necessity criteria and any prior authorization requests.

    Guideline supports use after conservative therapy but recognizes evidence limitations.

    Payer conclusion: Although studies and guidelines evaluate adhesiolysis in patients after failure of conservative therapies, the health plan concludes that current medical literature does not support the efficacy of lysis of epidural lesions and therefore does not favorably cover these procedures.

    Reflects policy coverage determination.

    'Health Plan' definition and related notes
    Definition'Health Plan' means a health plan that has adopted this clinical policy and that is operated or administered, in whole or in part, by Centene Management Company, LLC, or any of such health plan's affiliates.
    ScopeApplies to providers, members/enrollees, and their representatives bound by contract terms or by provision of services/submission of claims.
    Authority and limitationsClinical policy provides guidance on medical necessity and coverage decisions but does not guarantee payment or constitute a contract; Health Plan may change or withdraw the policy.
    Relation to state/Medicare rulesState Medicaid provisions take precedence where they conflict; Medicare NCDs/LCDs should be reviewed for Medicare members.